Categorical variables | Symptoms class of SCIN-total-score | Univariate | Multiple† | ||||||
---|---|---|---|---|---|---|---|---|---|
GST genotype | Number (%) | No (0–5) | Moderate (6–9) | Severe (10–18) | P | OR (95% CI) | P | OR (95% CI) | |
P1 | A/A | 99 (41.6) | 60 (60.6) | 23 (23.2) | 16 (16.2) | 0.098 | 2.03 (0.88–4.67) | 0.012 | 3.84 (1.34–10.75) |
A/G | 102 (42.9) | 53 (52.0) | 29 (28.4) | 20 (19.6) | 0.014 | 2.83 (1.24–6.46) | 0.003 | 4.95 (1.70–14.45) | |
G/G | 37 (15.5) | 27 (73.0) | 10 (27.0) | 0 (0) | Reference for GSTP1-AA and -AG | ||||
T1 | + | 201 (84.5) | 118 (58.7) | 51 (25.4) | 32 (15.9) | 0.770 | 1.11 (0.55–2.22) | 0.714 | 1.17 (0.50–2.73) |
- (ref.) | 37 (15.5) | 22 (59.5) | 11 (29.7) | 4 (10.8) | |||||
M1 | + | 134 (56.3) | 79 (59.0) | 35 (26.1) | 20 (14.9) | 0.947 | 0.98 (0.59–1.63) | 0.166 | 1.56 (0.83–2.94) |
- (ref.) | 104 (43.7) | 61 (58.7) | 27 (26.0) | 16 (15.4) | |||||
Continuous variables | TCSs N (%) | Median | Minimum | Maximum | |||||
Age at survey (OR for 10 years) | 238 (100%) | 42.3 | 22.7 | 73.4 | 0.008 | 1.40 (1.09–1.80) | 0.002 | 1.70 (1.22–2.36) | |
OR* | Cisplatin | 238 (100%) | 397 | 81 | 1571 | <0.001 | 1.35 (1.11–1.49) | 0.014 | 1.35 (1.06–1.71) |
Bleomycin | 226 (95.0%) | 142 | 0 | 212 | 0.040 | 1.65 (1.00–2.72) | 0.078 | 1.43 (0.93–2.13) | |
Vinblastine | 133 (55.9%) | 9.9 | 0 | 51 | 0.535 | 1.49 (0.41–6.05) | 0.319 | 0.23 (0.01–4.14) | |
Etoposide | 92 (38.7%) | 727 | 0 | 4934 | 0.092 | 1.00 (1.00–1.00) | 0.918 | 1.00 (0.90–1.11) |